Dow Down 1.29% Nasdaq Down 3.25%

Peregrine Pharmaceuticals, Inc. (PPHM)

-NasdaqCM
0.87 Down 0.03(3.37%) 4:00PM EST
|After Hours : 0.87 Up 0.00 (0.01%) 5:10PM EST - Nasdaq Real Time Price
Prev Close:0.90
Open:0.90
Bid:0.81 x 100
Ask:0.90 x 1000
1y Target Est:3.83
Beta:1.43971
Earnings Date:Mar 10 - Mar 14 (Est.)
Day's Range:0.87 - 0.93
52wk Range:0.86 - 1.66
Volume:1,053,812
Avg Vol (3m):1,123,820
Market Cap:199.82M
P/E (ttm):N/A
EPS (ttm):-0.29
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PPHM

Comparison

Symbol% ChgMkt Cap
PPHMDown 3.37%199.82M
AMGNDown 3.25%109.36B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.05
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Apr-16) :-0.29
Quarterly EPS Est (Jan-16) :-0.07
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops monoclonal antibodies for the treatment and diagnosis of cancer in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback